Sorry, your search for: did not find any results

Search Suggestions: Make sure your keyword(s) are spelled correctly Try another keyword(s) Try more general keyword(s)

Anaesthesia Delivery

GE's focus on innovation in anaesthesia delivery helps clinicians improve clinical outcomes with solutions that are tailored to individual patient needs. GE anaesthesia platforms are intuitive, integrated and adaptable - allowing you to focus on the patient.

Less

view

Prev Next

Tour:

Maintaining targeted patient oxygen concentration

Scientific evidence demonstrates that automatic oxygen delivery can reduce the number of adjustments needed to maintain the End tidal Oxygen level.

Automatic oxygen delivery can facilitate direct setting of the oxygen concentration and can maintain the oxygen delivery at a desired level. Since GE introduced the simple-to-use End tidal Control™ in 2010 on Aisys² and later on Aisys CS2, millions of patients were successfully treated with oxygen concentration targeted directly by their clinician for them.

Click to know more

Applying intraoperative lung protection ventilation

Scientific evidence demonstrates that prophylactic intraoperative lung protection ventilation strategy can minimize pulmonary complications.

The introduction of automated lung ventilation manoeuvres on GE anaesthesia devices has provided anaesthetists and nurses with a simple intraoperative solution to deliver protective lung ventilation to their patients.

Click here to know more

Optimizing drug delivery for enhanced patient care

Studies demonstrate how optimized drug delivery through parameter guided anaesthesia can reduce unwanted hemodynamic events, and shorten patient recovery time.

Accurate neuromuscular relaxation monitoring can help prevent post-operative residual curarization. Scientific evidence, shows how GE innovative parameters SPI5, Entropy™ & Electromyography NMT can help support adequate and personalized anaesthesia control for Advancing anaesthesia… together. enhanced patient sedation, analgesia and muscular relaxation.

Click here to know more

Advancing intraoperative pain response management

Since GE introduced the innovative Surgical Pleth Index (SPI)5 parameter, now there is a way to objectively monitor and detect hemodynamic responses to patient pain during general anaesthesia. Scientific publications demonstrate how SPI guides remifentanil administration to achieve the optimal dosage for the specific patient and significantly reduces adverse hemodynamic events.

Click to know more.

Optimizing anaesthetic agent delivery

A recent scientific publication describes that manual agent delivery during low fresh gas flow results in numerous adjustments to reach and maintain the desired agent concentration and may result in temporary agent overdosage to achieve the target agent concentration.

Automatic volatile agent delivery can support the clinician to reach and maintain the target volatile concentration in the therapeutic range.

Since GE introduced the End tidal Control™ in 2010 on Aisys3 and later on Aisys CS2, thousands of anaesthetists and nurses have successfully delivered anaesthetic treatment to their patients by targeting directly the desired volatile agent concentration.

Click to know more

Prediction of Post-Operative Pain with Surgical Pleth Index

Scientific evidence suggests that the nociception assessment variable Surgical Pleth Index (SPI) could help predict moderate to severe post operative pain when monitored before patient arousal^1,2,3.

1. Surgical pleth index: prediction of postoperative pain and influence of arousal. Ledowsky, BJA 117 (3): 371-4 (2016)

2. Sevoflurane-fentanyl based Anaesthesia

3. Reliability of the Surgical Pleth Index for assessment of postoperative pain. Bein at Al, Eur J Anaesthesiol 2014; 31:1–5

Click to know more

Optimizing Intubation and Extubation with accurate NMT technology

Scientific evidence demonstrates that Electromyography (EMG) neuromuscular transmission technology offers a better compromise for detecting rocuronium onset time and optimal intubating conditions in children compared to other technology¹. In adults, EMG assures minimization of residual neuromuscular block by reaching a TOF 90% extubation threshold compared to other technology².

1. Electromyography offers a better compromise than acceleromyography with respect to the duration of calibration process and surrogate for the optimal time of tracheal intubation in children.
Jung et Al, KJA 2016 Feb 69(1):21-26

2. An Ipsilateral Comparison of Acceleromyography and Electromyography During Recovery from Nondepolarizing Neuromuscular Block Under General Anesthesia in Humans.
Linag et Alias A&A August 2013 • Volume 117 • Number 2

Click to know more

Prev Next

Products
Drug Delivery Expertise
Lung Protection Strategy
Related Perioperative Solutions

Products

9100c NXT

9100c NXT is a precise anaesthesia solution that gives you peace of mind by supporting an easy and trustful anaesthesia delivery experience.

Carestation™ Insights

Carestation Insights is an advanced analytic platform that helps make data driven decisions to deliver improved outcomes.

Carestation 600 Series

Carestation 600 Series is a reliable and agile anaesthesia platform with smart tools to help simplify your daily work and manage non-ordinary events.

Aisys CS² with EtC

Our most advanced Carestation, the Aisys CS²* with End tidal Control (EtC) helps you focus on the patient, use time more efficiently and improve your workflow.

Avance CS2 Anaesthesia Carestation with CARESCAPE B650 Monitor

Avance CS2 with ecoFLOW

Clinicians skilled in the practice of low and minimal flow anaesthesia delivery understand that sometimes less is more.

Aespire View

The Aespire* View demonstrates how GE’s advanced technology leadership is helping drive the future of perioperative care.

Vaporizers and Cassettes

Our vaporizers are developed to delivery accuracy under a wide range of conditions.

Drug Delivery Expertise

Et Control

Get the benefits you need in a compact, integrated anaesthesia carestation

Adequacy of Anaesthesia

The Adequacy of Anaesthesia (AoA) concept signals GE Healthcare’s commitment to provide clinical measurements for the components required for general anaesthesia.

Advanced Breathing System

Our fast wash-in, wash-out times help anaesthesists perform efficiently and economically.

Navigator Applications Suite

A digital clinical decision support tool that puts relevant, reliable, and predictive information at your fingertips.

Lung Protection Strategy

Overview

Overcoming the challenge of ventilation during anesthesia.

Neonatal Patients

Overcome the challenge of effectively ventilating neonates.

Vital Capacity and Cycling

Vital Capacity and Cycling are two lung ventilation procedures to help caregivers in dealing with atelectasis.

CPAP PSV

With the CPAP PSV pressure support ventilation mode , Aisys CS2 brings ICU quality pressure support to the operating theatre.

Flow Power

Digital flow delivery technology helps clinicians reach targeted pressures quickly and maximize time available for gas exchange across patient categories.

*AoA and Et Control are not cleared or approved by the US FDA. Not for sale in the United States.

Anaesthesia Literature

Anaesthesia Drug Delivery brochure

PDF 2MB

Date Created: 11/30/2011
Document ID: DOC1057798

Open Interface Commitment

GE/Instrumentarium Interfacing Commitment to the European Union

As described in the Interfacing Commitment, GE is obligated to provide Interfacing information and data (such as protocol information) necessary to ensure an open Interface between GE's existing and future devices and third parties' devices in the product combinations listed below, and new Interfacing information relating to any Interface modification or upgrade of GE's devices.

Therefore, GE agrees to make available Interfacing information and data, as described in the Interfacing Commitment, between the following product combinations:

GE Therapy Devices, with respect to their combination with Patient Monitors or CIS
GE Patient Monitors, with respect to their combination with Therapy Devices or CIS
GE CIS, with respect to their combination with Therapy Devices and/or Patient Monitors Upon execution of an Interfacing Agreement with GE, third parties may use this Interfacing information, without charge, for the purpose of interfacing their devices in the product combinations listed above.

For additional information or to obtain an Interfacing Agreement, please feel free to contact:

Matthew McManus

Phone: (414) 721-4663
E-mail to: InterfaceCommitment@ge.com
Mail: GE Healthcare, 9900 Innovation Drive, RP-2131, Wauwatosa, WI 53226

Learn more about the Commitment made by GE to the European Commission.

Download the public version of GE's Interface Commitment. This document can also be accessed from the European Commission's website.

Interface Information and Selection Guide: Decision Matrix

	3rd Party Equipment
GE Equipment	Patient Monitor	Therapy Device	Clinical Information System
GE Patient Monitor	Unsupported - Request Custom Solution	GE Monitoring Interface Solutions	GE Monitoring Interface Solutions
GE Therapy Device	GE Therapy Interface Solutions	Unsupported - Request Custom Solution	GE Therapy Interface Solutions
GE Clinical Information System	GE Clinical Information Systems	GE Clinical Information Systems	Unsupported - Request Custom Solution

You Are Changing Sites

GE Healthcare

Sorry, your search for: did not find any results

Anaesthesia Delivery

Maintaining targeted patient oxygen concentration

Applying intraoperative lung protection ventilation

Optimizing drug delivery for enhanced patient care

Advancing intraoperative pain response management

Optimizing anaesthetic agent delivery

Prediction of Post-Operative Pain with Surgical Pleth Index

Optimizing Intubation and Extubation with accurate NMT technology

9100c NXT

Carestation™ Insights

Carestation 600 Series

Aisys CS² with EtC

Avance CS2 with ecoFLOW

Aespire View

Vaporizers and Cassettes